These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28694048)

  • 1. Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions.
    Carlson GS; Wong PH; White KM; Quinn JM
    J Allergy Clin Immunol Pract; 2017; 5(5):1430-1432. PubMed ID: 28694048
    [No Abstract]   [Full Text] [Related]  

  • 2. Half of systemic reactions to allergen immunotherapy are delayed, majority require treatment with epinephrine.
    Cook KA; Ford CM; Leyvas EA; Waalen J; White AA
    J Allergy Clin Immunol Pract; 2017; 5(5):1415-1417. PubMed ID: 28454684
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors do not impair the safety of Hymenoptera venom immunotherapy build-up phase.
    Stoevesandt J; Hain J; Stolze I; Kerstan A; Trautmann A
    Clin Exp Allergy; 2014; 44(5):747-55. PubMed ID: 24447144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis.
    Salvador GL; Marmentini VM; Cosmo WR; Junior EL
    Eur J Prev Cardiol; 2017 Dec; 24(18):1914-1924. PubMed ID: 28862020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing practice: no need to stop ACE inhibition for venom immunotherapy.
    Slade CA; Douglass JA
    Clin Exp Allergy; 2014; 44(5):617-9. PubMed ID: 24734926
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study.
    Chen R; Suchard MA; Krumholz HM; Schuemie MJ; Shea S; Duke J; Pratt N; Reich CG; Madigan D; You SC; Ryan PB; Hripcsak G
    Hypertension; 2021 Sep; 78(3):591-603. PubMed ID: 34304580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers.
    Tazkarji B; Ganeshamoorthy A; Auten B
    Am Fam Physician; 2015 Feb; 91(3):193-4. PubMed ID: 25822274
    [No Abstract]   [Full Text] [Related]  

  • 8. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Inquiry: Do ACE inhibitors or ARBs help prevent kidney disease in patients with diabetes and normal BP?
    Trietley GS; Wilson SA; Chaudhri P; Payette N; Higbea A; Nashelsky J
    J Fam Pract; 2017 Apr; 66(4):257-263. PubMed ID: 28375400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and safety of dual renin-angiotensin system blockade: a comparison between younger and older cohorts.
    Urshila S; Mergenhagen KA; Kellick K
    Consult Pharm; 2013 Jun; 28(6):383-9. PubMed ID: 23748126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral immunotherapy for peanut allergy: multipractice experience with epinephrine-treated reactions.
    Wasserman RL; Factor JM; Baker JW; Mansfield LE; Katz Y; Hague AR; Paul MM; Sugerman RW; Lee JO; Lester MR; Mendelson LM; Nacshon L; Levy MB; Goldberg MR; Elizur A
    J Allergy Clin Immunol Pract; 2014; 2(1):91-6. PubMed ID: 24565775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and characteristics of biphasic reactions after allergen immunotherapy.
    Scranton SE; Gonzalez EG; Waibel KH
    J Allergy Clin Immunol; 2009 Feb; 123(2):493-8. PubMed ID: 19064282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating for seasonal variation in angiotensin-converting enzyme inhibitor- and angiotensin receptor blocker-induced angioedema.
    Wilson M; Frohna W; Trent G; Sauter D
    Ann Allergy Asthma Immunol; 2014 Feb; 112(2):178-9. PubMed ID: 24468261
    [No Abstract]   [Full Text] [Related]  

  • 14. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
    Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
    Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.
    Derosa G; Maffioli P
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):719-28. PubMed ID: 23750681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up.
    Fici F; Seravalle G; Koylan N; Nalbantgil I; Cagla N; Korkut Y; Quarti-Trevano F; Makel W; Grassi G
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):289-296. PubMed ID: 28497339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine.
    Phillips JF; Lockey RF; Fox RW; Ledford DK; Glaum MC
    Allergy Asthma Proc; 2011; 32(4):288-94. PubMed ID: 21781404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical usefulness of RAAS inhibitors in hypertensive patients].
    Yamaguchi K; Sata M
    Nihon Rinsho; 2012 Sep; 70(9):1571-6. PubMed ID: 23012805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending the targets for antihypertensive drugs.
    Bonn D
    Lancet; 1998 Aug; 352(9125):378. PubMed ID: 9717937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.